63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 363 / 薬物数 : 212 - (DrugBank : 43) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 138

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05232149 (ClinicalTrials.gov)	February 2022	20/12/2021	A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocy ...	A Randomized, Multi-center, Adaptive Phase IIa/IIb Study to Evaluate the Efficacy and Safety of Orel ...	Primary Immune Thrombocytopenia	Drug: Orelabrutinib ( lower dose);Drug: Orelabrutinib ( higher dose)	Beijing InnoCare Pharma Tech Co., Ltd.	NULL	Not yet recruiting	18 Years	80 Years	All	30	Phase 2	China

First Previous1Next Last